Biospecimen Repository for Cardiac Arrhythmias at the Cleveland Clinic
The long-term objective of this research is to find genes and biologic pathways causing arrhythmia syndromes and other diseases or conditions. In order to achieve this objective the investigators will collect comprehensive phenotypic data and corresponding blood and/or tissue samples into a biorepository registry of patients, presenting for cardiac arrhythmia evaluation and/or treatment, and...
Brief Summary
Official Title: “Cleveland Clinic Arrhythmia Biospecimen Repository (Cleveland Clinic Arrhythmia BioBank)”
The long-term objective of this research is to find genes and biologic pathways causing arrhythmia syndromes and other diseases or conditions. In order to achieve this objective the investigators will collect comprehensive phenotypic data and corresponding blood and/or tissue samples into a biorepository registry of patients, presenting for cardiac arrhythmia evaluation and/or treatment, and control subjects without arrhythmias. This biorepository will be composed of two parts: 1) An Arrhythmia Biorepository of blood and tissue from patients undergoing arrhythmia procedures, cardiac surgery, or inpatient or outpatient evaluations for arrhythmias, and 2) A Collaborative Sample Biorepository for deidentified samples and data from outside institutions and clinical trials.
- Study Type: Observational
- Study Design: Observational Model: Case Control, Time Perspective: Prospective
Detailed Clinical Trial Description
One time blood draw and follow up in one year.
Arms, Groups and Cohorts in this Clinical Trial
- : Arrhythmias
- Patients with arrhythmias
- : Control Subjects
- Subjects that do not have a history of cardiac arrhythmias.
Outcome Measures for this Clinical Trial
Primary Measures
- Various Arrhythmias
- Time Frame: Indefinite
Safety Issue?: No
- Time Frame: Indefinite
Criteria for Participation in this Clinical Trial
Inclusion Criteria:
- Male or female at least 18 years old
- Subjects with a history of or current cardiac arrhythmia, family members of subjects with cardiac arrhythmias, or no cardiac arrhythmia if a Control Subject.
Exclusion Criteria:
- Subjects previously enrolled in the Arrhythmia BioBank
Gender Eligibility for this Clinical Trial: Both
Minimum Age for this Clinical Trial: 18 Years
Maximum Age for this Clinical Trial: N/A
Are Healthy Volunteers Accepted for this Clinical Trial?: Accepts Healthy Volunteers
Clinical Trial Investigator Information
Lead Investigator: The Cleveland Clinic Other
Overall Clinical Trial Officials and Contacts
Mina K. Chung, MD Principal Investigator The Cleveland Clinic
Overall Contact: Mina K. Chung, MD 216.444.2290 chungm@ccf.org
Additional Information
Information obtained from ClinicalTrials.gov on February 09, 2012
Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00921986
Study ID Number: 09-176
ClinicalTrials.gov Identifier: NCT00921986
Health Authority: United States: Institutional Review Board
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is:
http://clinicaltrialsfeeds.org/clinical-trials/show/NCT00921986
